Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment planning considerations for 125I eye plaque brachytherapy.
Miguel D, de Frutos JM, López-Lara F, Alonso P, Diezhandino P, Saornil MA, García C. Miguel D, et al. Among authors: diezhandino p. J Contemp Brachytherapy. 2019 Jun;11(3):280-284. doi: 10.5114/jcb.2019.86370. Epub 2019 Jun 28. J Contemp Brachytherapy. 2019. PMID: 31435435 Free PMC article.
Primary conjunctival follicular lymphoma mimicking chronic conjunctivitis.
Labrador Velandia S, García Lagarto E, Saornil MA, García Álvarez C, Cuello R, Diezhandino P. Labrador Velandia S, et al. Among authors: diezhandino p. Arch Soc Esp Oftalmol. 2016 Feb;91(2):86-9. doi: 10.1016/j.oftal.2015.09.013. Epub 2015 Nov 11. Arch Soc Esp Oftalmol. 2016. PMID: 26560164
Radiobiological doses, tumor, and treatment features influence on local control, enucleation rates, and survival after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: part I.
Miguel D, de Frutos-Baraja JM, López-Lara F, Saornil MA, García-Álvarez C, Alonso P, Diezhandino P. Miguel D, et al. Among authors: diezhandino p. J Contemp Brachytherapy. 2018 Aug;10(4):337-346. doi: 10.5114/jcb.2018.77849. Epub 2018 Aug 31. J Contemp Brachytherapy. 2018. PMID: 30237817 Free PMC article.
Radiobiological doses, tumor, and treatment features influence on outcomes after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: part II.
Miguel D, de Frutos-Baraja JM, López-Lara F, Saornil MA, García-Álvarez C, Alonso P, Diezhandino P. Miguel D, et al. Among authors: diezhandino p. J Contemp Brachytherapy. 2018 Aug;10(4):347-359. doi: 10.5114/jcb.2018.77955. Epub 2018 Aug 31. J Contemp Brachytherapy. 2018. PMID: 30237818 Free PMC article.
Status of head and neck brachytherapy in Spain in 2022.
Guinot JL, Diezhandino P, de Frutos JM, Fuentemilla N, Gonzalez-Perez V, Gutierrez C, Herreros A, Martinez-Monge R, Perez-Echagüen S, Pino F, Roldán S, Rovirosa A, Santos MA, Sanz-Freire CJ, Villafranca E. Guinot JL, et al. Among authors: diezhandino p. Clin Transl Oncol. 2024 Feb;26(2):456-460. doi: 10.1007/s12094-023-03265-8. Epub 2023 Aug 7. Clin Transl Oncol. 2024. PMID: 37548869
13 results